NCT00555048 2017-05-24Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic CancerFred Hutchinson Cancer CenterPhase 1/2 Terminated1 enrolled 5 charts
NCT00787761 2012-10-01Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological CancerNorthside Hospital, Inc.Phase 2 Completed24 enrolled 13 charts